J Catalin

1.2k total citations
61 papers, 1.0k citations indexed

About

J Catalin is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, J Catalin has authored 61 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Molecular Biology and 15 papers in Pharmacology. Recurrent topics in J Catalin's work include Cancer Treatment and Pharmacology (14 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Cancer therapeutics and mechanisms (9 papers). J Catalin is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Cancer therapeutics and mechanisms (9 papers). J Catalin collaborates with scholars based in France, Netherlands and Chile. J Catalin's co-authors include Bruno Lacarelle, Alain Durand, Joseph Ciccolini, Alain Durand, Suzanne Monjanel‐Mouterde, Pierre‐Henri Villard, Laurence Attolini, H. Bun, Pierre Lafforgue and Eric Sérée and has published in prestigious journals such as Cancer, Biochemical and Biophysical Research Communications and British Journal of Cancer.

In The Last Decade

J Catalin

61 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Catalin France 19 321 297 207 143 106 61 1.0k
Jean‐Paul Cano France 18 341 1.1× 242 0.8× 183 0.9× 90 0.6× 61 0.6× 39 919
Camille Granvil United States 17 303 0.9× 414 1.4× 328 1.6× 65 0.5× 202 1.9× 34 1.0k
Stanislav Mičuda Czechia 24 472 1.5× 405 1.4× 209 1.0× 110 0.8× 92 0.9× 97 1.5k
Dennis C. Mays United States 21 150 0.5× 396 1.3× 160 0.8× 274 1.9× 166 1.6× 56 1.4k
A. Bernareggi United States 22 432 1.3× 399 1.3× 131 0.6× 54 0.4× 138 1.3× 63 1.3k
Alain Deroussent France 21 402 1.3× 529 1.8× 149 0.7× 139 1.0× 98 0.9× 47 1.5k
J. H. Beijnen Netherlands 20 810 2.5× 412 1.4× 176 0.9× 80 0.6× 141 1.3× 47 1.4k
M Hroch Czechia 20 259 0.8× 198 0.7× 129 0.6× 111 0.8× 133 1.3× 70 1.0k
Michele Visentin Switzerland 19 412 1.3× 581 2.0× 135 0.7× 103 0.7× 116 1.1× 55 1.8k
Yasuna Kobayashi Japan 19 784 2.4× 350 1.2× 267 1.3× 125 0.9× 48 0.5× 51 1.4k

Countries citing papers authored by J Catalin

Since Specialization
Citations

This map shows the geographic impact of J Catalin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Catalin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Catalin more than expected).

Fields of papers citing papers by J Catalin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Catalin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Catalin. The network helps show where J Catalin may publish in the future.

Co-authorship network of co-authors of J Catalin

This figure shows the co-authorship network connecting the top 25 collaborators of J Catalin. A scholar is included among the top collaborators of J Catalin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Catalin. J Catalin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doz, François, Jean Claude Gentet, F Pein, et al.. (2001). Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study. British Journal of Cancer. 84(5). 604–610. 30 indexed citations
2.
Ciccolini, Joseph, et al.. (2001). Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid–liquid extraction. Journal of Chromatography B Biomedical Sciences and Applications. 759(2). 299–306. 50 indexed citations
3.
Bun, H., et al.. (1999). Interspecies variability and drug interactions of clozapine metabolism by microsomes. Fundamental and Clinical Pharmacology. 13(5). 577–581. 21 indexed citations
4.
Sérée, Eric, Michel De Méo, Bruno Lacarelle, et al.. (1996). High Inducibility of Mouse Renal CYP2E1 Gene by Tobacco Smoke and Its Possible Effect on DNA Single Strand Breaks. Biochemical and Biophysical Research Communications. 219(2). 429–434. 38 indexed citations
5.
Lafforgue, Pierre, et al.. (1995). Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.. PubMed. 22(5). 844–9. 48 indexed citations
6.
Catalin, J, et al.. (1995). Pharmacokinetics and metabolism of pirarubicin in humans: correlation with pharmacodynamics. Cancer Chemotherapy and Pharmacology. 36(3). 239–243. 8 indexed citations
7.
Pignon, T., Bruno Lacarelle, Florence Duffaud, et al.. (1995). Dosage Adjustment of High-Dose Methotrexate Using Bayesian Estimation. Therapeutic Drug Monitoring. 17(5). 471–478. 14 indexed citations
8.
Lacarelle, Bruno, et al.. (1995). Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.. British Journal of Clinical Pharmacology. 40(1). 83–86. 17 indexed citations
9.
Guellec, Chantal Le, et al.. (1995). Glucuronidation of Propofol in Microsomal Fractions from Various Tissues and Species Including Humans. Anesthesia & Analgesia. 81(4). 855–861. 60 indexed citations
10.
Tubiana-Mathieu, N., et al.. (1994). Pharmacokinetics of folinic acid and 5-methyltetrahydrofolic metabolite after repeated oral administration of calcium folinate following methotrexate treatment. European Journal of Cancer. 30(9). 1281–1284. 2 indexed citations
11.
Astoul, P., et al.. (1994). Pharmacokinetics of intrapleural recombinant interleukin-2 in immunotherapy for malignant pleural effusion. Cancer. 73(2). 308–313. 18 indexed citations
12.
Gauthier, Thomas, et al.. (1994). Predictive performance of two software packages (USC ∗ PACK PC and Abbott PKS system) for the individualization of amikacin dosage in intensive care unit patients. International Journal of Bio-Medical Computing. 36(1-2). 131–134. 10 indexed citations
13.
Lacarelle, Bruno, et al.. (1991). Use of a human liver microsome bank in drug glucuronidation studies. Toxicology in Vitro. 5(5-6). 559–562. 4 indexed citations
14.
Lacarelle, Bruno, et al.. (1991). Use of human and animal liver microsomes in drug metabolic studies.. PubMed. Spec No 3. 458–65. 3 indexed citations
15.
Lacarelle, Bruno, et al.. (1991). In vitro glucuronidation of 3'-azido-3'-deoxythymidine by human liver. Role of UDP-glucuronosyltransferase 2 form.. Drug Metabolism and Disposition. 19(4). 809–815. 32 indexed citations
16.
Catalin, J, et al.. (1988). Direct determination of mitoxantrone and its mono- and dicarboxylic metabolites in plasma and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 424(2). 337–345. 25 indexed citations
17.
Fabre, G, et al.. (1983). In vitro approach to 7-hydroxymethotrexate interaction on methotrexate metabolism as tool of pharmacokinetic study.. PubMed. 3(6). 475–84. 4 indexed citations
18.
Cano, J. P., et al.. (1982). Platinum determination in plasma and urine by flameless atomic absorption spectrophotometry. Journal of Applied Toxicology. 2(1). 33–38. 7 indexed citations
19.
Catalin, J, et al.. (1970). Détermination de la nicotine par chromatographie en phase gazeuse. II. Applications.. Annales Pharmaceutiques Françaises. 28(11). 4 indexed citations
20.
Catalin, J, et al.. (1970). [Determination of nicotine by gas-phase chromatography. II. Applications].. PubMed. 28(11). 633–40. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Paul Cano Breakdown of academic impact, for papers by Camille Granvil Breakdown of academic impact, for papers by Stanislav Mičuda Breakdown of academic impact, for papers by Dennis C. Mays Breakdown of academic impact, for papers by A. Bernareggi Breakdown of academic impact, for papers by Alain Deroussent Breakdown of academic impact, for papers by J. H. Beijnen Breakdown of academic impact, for papers by M Hroch Breakdown of academic impact, for papers by Michele Visentin Breakdown of academic impact, for papers by Yasuna Kobayashi
Rankless by CCL
2026